New York-based ProofPilot, a frontrunner in the Clinical Experience Platform (CXP) space, has announced the successful closing of its Series C funding round. Sopris Capital led the investment, with participation from Mitsui & Co. (U.S.A.), Inc. This significant investment underscores the growing recognition of ProofPilot’s innovative approach to clinical trials. While advancements in data capture…
Bedal International, a pioneering medical device company specializing in advanced catheter securement solutions, has successfully concluded an $11 million funding round aimed at accelerating its global expansion efforts. The funding will bolster Bedal’s capacity to further innovate and meet the growing demand for its flagship product, the FlexGRIP® catheter securement devices. Led by Belgian MedTech…
Octagos Health, a trailblazer in AI-driven cardiac device monitoring solutions, has successfully concluded its Series C funding round with an impressive $43 million in investment capital. The round was led by Morgan Stanley Expansion Capital, underscoring confidence in Octagos Health’s transformative technologies aimed at revolutionizing cardiac care through advanced artificial intelligence. Octagos Health specializes in…
Nagish, a pioneering startup dedicated to enhancing communication accessibility for deaf and hard-of-hearing individuals using AI technology, has announced a significant milestone with the securing of $16 million in funding. This round includes $11 million from Series A led by Canaan Partners, with additional support from existing investors K5 Global, Tokyo Black, Cardumen Capital, Vertex…
VenoStent, Inc., a leading innovator in medical devices aimed at enhancing outcomes for dialysis patients, has successfully closed its Series A funding round, securing $20 million. This round was highlighted by a significant $4 million investment from Norwest Venture Partners, alongside contributions from Good Growth Capital and IAG Capital Partners. Concurrently, the company has been…
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a pioneering biopharmaceutical firm renowned for its innovative approach to severe ischemic diseases, has announced a significant milestone today. The company successfully finalized agreements for a private placement offering, securing $11.8 million in gross proceeds from accredited investors. This strategic funding round underscores DiaMedica’s commitment to advancing clinical and product…
London-based healthtech startup Cryogenx has successfully raised £800,000 in funding to advance its groundbreaking portable body cooling device, CGX1. This investment round includes a significant contribution of £150,000 from the British Design Fund, alongside support from existing shareholders, angel investors, and a US-based fund. Founded by Matt Anderson, Cryogenx aims to address the critical need…
Zuub, a trailblazer in dental Revenue Cycle Automation, has marked a significant milestone with the closing of a $9 million Series A funding round. Led by Vertical Venture Partners, with participation from existing investors Bonfire Ventures and MTech Capital, this funding underscores Zuub’s commitment to transforming dental practice operations through advanced artificial intelligence and automation…
Qure.ai Technologies Limited has secured a significant strategic investment from the Merck Global Health Innovation Fund in its latest Series D funding round. This partnership marks a pivotal moment for advancing artificial intelligence (AI) in healthcare, particularly in the realm of medical imaging. Qure.ai, renowned for its groundbreaking AI applications, including early detection tools for…
UroMems, a pioneering global company specializing in mechatronics technology for treating stress urinary incontinence (SUI), has secured $47 million in its Series C financing round, marking a record fundraising achievement for the company. This capital infusion will propel pivotal clinical trials of their groundbreaking UroActive™ System, the world’s first smart automated artificial urinary sphincter (AUS)…
